S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

OCX Oncocyte Corporation

2.3177

0.0877 (3.93%)

Last Updated: 10:48:50

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Oncocyte (NASDAQ:OCX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Oncocyte Charts.

Oncocyte (NASDAQ:OCX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Oncocyte Charts.

Oncocyte Corporation News

Form 8-K - Current report
Wednesday 8 January 2025 (2 days ago) • Edgar (US Regulatory)

Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer
Wednesday 8 January 2025 (2 days ago) • GlobeNewswire Inc.

Oncocyte Expands Market Opportunity for VitaGraft™ Kidney
Monday 6 January 2025 (4 days ago) • GlobeNewswire Inc.

Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings
Monday 9 December 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 9 December 2024 (1 month ago) • Edgar (US Regulatory)

Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
Wednesday 4 December 2024 (1 month ago) • GlobeNewswire Inc.

Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms
Monday 2 December 2024 (1 month ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
Tuesday 12 November 2024 (2 months ago) • GlobeNewswire Inc.

Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
Wednesday 6 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 22 October 2024 (3 months ago) • Edgar (US Regulatory)

More Oncocyte Corporation News Articles

Illinois Tool Works

Bofa Finance Llc Autocal...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions